Ligand profile
CHEMBL107516
Bioactivity hit from ChEMBL on a similar protein.
Bound to: VK055_0532 — alpha/beta hydrolase fold family protein
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL107516- UniProt (similar protein)
P04058- pchembl
- 8.620 (~2.4 nM)
- Target protein
- VK055_0532
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 38.9
- −1 ≤ LogP ≤ 5 3.74
- MW ≤ 500 Da 246.7
- LogP ≤ 5 3.74
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 2
- Rotatable bonds ≤ 10 0
- TPSA ≤ 140 Ų 38.9
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Nc1c2c(nc3cccc(Cl)c13)CCCCC2Nc1c2c(nc3cccc(Cl)c13)CCCCC2
InChI=1S/C14H15ClN2/c15-10-6-4-8-12-13(10)14(16)9-5-2-1-3-7-11(9)17-12/h4,6,8H,1-3,5,7H2,(H2,16,17)InChI=1S/C14H15ClN2/c15-10-6-4-8-12-13(10)14(16)9-5-2-1-3-7-11(9)17-12/h4,6,8H,1-3,5,7H2,(H2,16,17)
KAAAIHLOSOSBCH-UHFFFAOYSA-NKAAAIHLOSOSBCH-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Binding sites
- PF00135
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL107516 →
- UniProt UniProt P04058 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL107516”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_0532.
PDB 17
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 99
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).